Investor Relations

Investor Relations

Investor Relations

Stock Snapshot

Investor Relations

Stock Snapshot

Scorpius Holdings, Inc.

Company Overview

Scorpius Holdings Inc. through its Scorpius BioManufacturing subsidiary, is an integrated contract development and manufacturing organization (CDMO) focused on rapidly advancing biologic programs to the clinic and beyond. Scorpius offers a broad array analytical testing, process development, and manufacturing services to pharmaceutical and biotech companies at its state-of-the art facilities in San Antonio, TX. With an experienced team and new, purpose-built U.S. facilities, Scorpius is dedicated to transparent collaboration and flexible, high-quality biologics biomanufacturing.

Latest Financial Results

Q3 2023

Quarter Ended Sep 30, 2023

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2022

IR Contacts

Company

Scorpius Holdings, Inc.
627 Davis Drive
Suite 300
Morrisville, NC 27560
ir@scorpiusbiologics.com

Investor Relations

SCPX@crescendo-ir.com

Transfer Agent

Continental Stock Transfer & Trust Company
17 Battery Place, 8th Floor
New York, NY 10004
T: +1 212 509 4000

Connect With Us